drugset / Trial / NCT05370898
The Study of Chinese Medicine for the Treatment of Primary Osteoporosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and possible mechanism of traditional Chinese medicine in the treatment of primary osteoporosis (Kidney Yang Deficiency Syndrome).It is a randomized, placebo-controlled trial.
Timeline
- Start
- 2022-07-01
- Primary completion
- 2022-12-01
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chinese medicine prescription | Traditional medicine (herbal / TCM) | 200 ml | Oral |
| Background | Caltrate D | Unknown | — | Oral |